レミケードバイオシミラーの世界市場 2020年-2024年

9Dimen Researchが発行した調査報告書(DIM20NV1165)
◆英語タイトル:Global Remicade Biosimilar Market Research Report 2020-2024
◆商品コード:DIM20NV1165
◆発行会社(リサーチ会社):9Dimen Research
◆発行日:2020年11月6日(※2024年版があります。お問い合わせください。)
◆ページ数:151
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,850 ⇒換算¥421,800見積依頼/購入/質問フォーム
Global/Corporate UserUSD5,800 ⇒換算¥858,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社は9Dimen Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。9Dimen Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料は、世界のレミケードバイオシミラー市場2020-2024について調査・分析し、レミケードバイオシミラーの世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、アジア市場動向、北アメリカ市場動向、ヨーロッパ市場動向、マーケティングチャネル分析、投資可能性分析、メーカー分析などの情報を掲載しています。また、種類別(組み換え非グリコシル化タンパク質、組み換えグリコシル化タンパク質、ペプチド、……など)、用途別(血液疾患、腫瘍疾患、慢性及び自己免疫疾患、成長ホルモン欠乏症、……など)のセグメント情報も収録しています。
・レミケードバイオシミラーの市場概要
・レミケードバイオシミラーの上流・下流市場分析
・レミケードバイオシミラーのアジア市場:市場分析(製品開発、競争環境、市場動向等)
・レミケードバイオシミラーのアジア市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・レミケードバイオシミラーのアジア市場:主要メーカー分析(Teva Pharmaceutical Industries Ltd.、Synthon Pharmaceuticals, Inc.、LG Life Sciences、Novartis (Sandoz)、Celltrion、……)
・レミケードバイオシミラーのアジア市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・レミケードバイオシミラーの北アメリカ市場:市場分析(製品開発、競争環境、市場動向等)
・レミケードバイオシミラーの北アメリカ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・レミケードバイオシミラーの北アメリカ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・レミケードバイオシミラーの北アメリカ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・レミケードバイオシミラーのヨーロッパ市場:市場分析(製品開発、競争環境、市場動向等)
・レミケードバイオシミラーのヨーロッパ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・レミケードバイオシミラーのヨーロッパ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・レミケードバイオシミラーのヨーロッパ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・レミケードバイオシミラーのマーケティングチャネル分析
・マクロ経済分析(中国経済、ヨーロッパ経済、アメリカ経済、日本経済、グローバル経済)
・レミケードバイオシミラーの投資可能性分析
・レミケードバイオシミラーの世界市場規模(2015-2020年推移、2020-2024年予測)
...
【レポートの概要】

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, growing prevalence of chronic diseases among aging population are the prime growth drivers of global remicade biosimilar market. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Remicade Biosimilar Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Remicade Biosimilar market is valued at USD XX million in 2020 and is projected to reach USD XX million by the end of 2024, growing at a CAGR of XX% during the period 2020 to 2024.

The report firstly introduced the Remicade Biosimilar basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Teva Pharmaceutical Industries Ltd.
Synthon Pharmaceuticals, Inc.
LG Life Sciences
Novartis (Sandoz)
Celltrion
……

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Recombinant Non-Glycosylated Protein
Recombinant Glycosylated Protein
Peptides
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Remicade Biosimilar for each application, including-
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
……

【レポートの目次】

Table of Contents

Part I Remicade Biosimilar Industry Overview

Chapter One Remicade Biosimilar Industry Overview
1.1 Remicade Biosimilar Definition
1.2 Remicade Biosimilar Classification Analysis
1.2.1 Remicade Biosimilar Main Classification Analysis
1.2.2 Remicade Biosimilar Main Classification Share Analysis
1.3 Remicade Biosimilar Application Analysis
1.3.1 Remicade Biosimilar Main Application Analysis
1.3.2 Remicade Biosimilar Main Application Share Analysis
1.4 Remicade Biosimilar Industry Chain Structure Analysis
1.5 Remicade Biosimilar Industry Development Overview
1.5.1 Remicade Biosimilar Product History Development Overview
1.5.1 Remicade Biosimilar Product Market Development Overview
1.6 Remicade Biosimilar Global Market Comparison Analysis
1.6.1 Remicade Biosimilar Global Import Market Analysis
1.6.2 Remicade Biosimilar Global Export Market Analysis
1.6.3 Remicade Biosimilar Global Main Region Market Analysis
1.6.4 Remicade Biosimilar Global Market Comparison Analysis
1.6.5 Remicade Biosimilar Global Market Development Trend Analysis

Chapter Two Remicade Biosimilar Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Remicade Biosimilar Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Remicade Biosimilar Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Remicade Biosimilar Market Analysis
3.1 Asia Remicade Biosimilar Product Development History
3.2 Asia Remicade Biosimilar Competitive Landscape Analysis
3.3 Asia Remicade Biosimilar Market Development Trend

Chapter Four 2015-2020 Asia Remicade Biosimilar Productions Supply Sales Demand Market Status and Forecast
4.1 2015-2020 Remicade Biosimilar Production Overview
4.2 2015-2020 Remicade Biosimilar Production Market Share Analysis
4.3 2015-2020 Remicade Biosimilar Demand Overview
4.4 2015-2020 Remicade Biosimilar Supply Demand and Shortage
4.5 2015-2020 Remicade Biosimilar Import Export Consumption
4.6 2015-2020 Remicade Biosimilar Cost Price Production Value Gross Margin

Chapter Five Asia Remicade Biosimilar Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information


Chapter Six Asia Remicade Biosimilar Industry Development Trend
6.1 2020-2024 Remicade Biosimilar Production Overview
6.2 2020-2024 Remicade Biosimilar Production Market Share Analysis
6.3 2020-2024 Remicade Biosimilar Demand Overview
6.4 2020-2024 Remicade Biosimilar Supply Demand and Shortage
6.5 2020-2024 Remicade Biosimilar Import Export Consumption
6.6 2020-2024 Remicade Biosimilar Cost Price Production Value Gross Margin

Part III North American Remicade Biosimilar Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Remicade Biosimilar Market Analysis
7.1 North American Remicade Biosimilar Product Development History
7.2 North American Remicade Biosimilar Competitive Landscape Analysis
7.3 North American Remicade Biosimilar Market Development Trend

Chapter Eight 2015-2020 North American Remicade Biosimilar Productions Supply Sales Demand Market Status and Forecast
8.1 2015-2020 Remicade Biosimilar Production Overview
8.2 2015-2020 Remicade Biosimilar Production Market Share Analysis
8.3 2015-2020 Remicade Biosimilar Demand Overview
8.4 2015-2020 Remicade Biosimilar Supply Demand and Shortage
8.5 2015-2020 Remicade Biosimilar Import Export Consumption
8.6 2015-2020 Remicade Biosimilar Cost Price Production Value Gross Margin

Chapter Nine North American Remicade Biosimilar Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information


Chapter Ten North American Remicade Biosimilar Industry Development Trend
10.1 2020-2024 Remicade Biosimilar Production Overview
10.2 2020-2024 Remicade Biosimilar Production Market Share Analysis
10.3 2020-2024 Remicade Biosimilar Demand Overview
10.4 2020-2024 Remicade Biosimilar Supply Demand and Shortage
10.5 2020-2024 Remicade Biosimilar Import Export Consumption
10.6 2020-2024 Remicade Biosimilar Cost Price Production Value Gross Margin

Part IV Europe Remicade Biosimilar Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Remicade Biosimilar Market Analysis
11.1 Europe Remicade Biosimilar Product Development History
11.2 Europe Remicade Biosimilar Competitive Landscape Analysis
11.3 Europe Remicade Biosimilar Market Development Trend

Chapter Twelve 2015-2020 Europe Remicade Biosimilar Productions Supply Sales Demand Market Status and Forecast
12.1 2015-2020 Remicade Biosimilar Production Overview
12.2 2015-2020 Remicade Biosimilar Production Market Share Analysis
12.3 2015-2020 Remicade Biosimilar Demand Overview
12.4 2015-2020 Remicade Biosimilar Supply Demand and Shortage
12.5 2015-2020 Remicade Biosimilar Import Export Consumption
12.6 2015-2020 Remicade Biosimilar Cost Price Production Value Gross Margin

Chapter Thirteen Europe Remicade Biosimilar Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information


Chapter Fourteen Europe Remicade Biosimilar Industry Development Trend
14.1 2020-2024 Remicade Biosimilar Production Overview
14.2 2020-2024 Remicade Biosimilar Production Market Share Analysis
14.3 2020-2024 Remicade Biosimilar Demand Overview
14.4 2020-2024 Remicade Biosimilar Supply Demand and Shortage
14.5 2020-2024 Remicade Biosimilar Import Export Consumption
14.6 2020-2024 Remicade Biosimilar Cost Price Production Value Gross Margin

Part V Remicade Biosimilar Marketing Channels and Investment Feasibility

Chapter Fifteen Remicade Biosimilar Marketing Channels Development Proposals Analysis
15.1 Remicade Biosimilar Marketing Channels Status
15.2 Remicade Biosimilar Marketing Channels Characteristic
15.3 Remicade Biosimilar Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Remicade Biosimilar New Project Investment Feasibility Analysis
17.1 Remicade Biosimilar Market Analysis
17.2 Remicade Biosimilar Project SWOT Analysis
17.3 Remicade Biosimilar New Project Investment Feasibility Analysis

Part VI Global Remicade Biosimilar Industry Conclusions

Chapter Eighteen 2015-2020 Global Remicade Biosimilar Productions Supply Sales Demand Market Status and Forecast
18.1 2015-2020 Remicade Biosimilar Production Overview
18.2 2015-2020 Remicade Biosimilar Production Market Share Analysis
18.3 2015-2020 Remicade Biosimilar Demand Overview
18.4 2015-2020 Remicade Biosimilar Supply Demand and Shortage
18.5 2015-2020 Remicade Biosimilar Import Export Consumption
18.6 2015-2020 Remicade Biosimilar Cost Price Production Value Gross Margin

Chapter Nineteen Global Remicade Biosimilar Industry Development Trend
19.1 2020-2024 Remicade Biosimilar Production Overview
19.2 2020-2024 Remicade Biosimilar Production Market Share Analysis
19.3 2020-2024 Remicade Biosimilar Demand Overview
19.4 2020-2024 Remicade Biosimilar Supply Demand and Shortage
19.5 2020-2024 Remicade Biosimilar Import Export Consumption
19.6 2020-2024 Remicade Biosimilar Cost Price Production Value Gross Margin

Chapter Twenty Global Remicade Biosimilar Industry Research Conclusions



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ レミケードバイオシミラーの世界市場 2020年-2024年(Global Remicade Biosimilar Market Research Report 2020-2024)]についてメールでお問い合わせはこちらでお願いします。